Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s share price traded down 24.7% on Monday . The stock traded as low as $1.13 and last traded at $1.13. 2,300 shares were traded during mid-day trading, an increase of 82% from the average session volume of 1,267 shares. The stock had previously closed at $1.50.
Silence Therapeutics Trading Down 24.7 %
The company’s 50-day simple moving average is $1.49 and its 200-day simple moving average is $3.33.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
See Also
- Five stocks we like better than Silence Therapeutics
- 3 Dividend Kings To Consider
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Profitably Trade Stocks at 52-Week Highs
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Compound Interest and Why It Matters When Investing
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
